IRCT20150817023666N15招募中3 期
Comparison of intra-myomic injection of oxytocin and intramural vasopressin in reducing laparoscopic myomectomy bleeding in women with myoma
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 45 years（—）
- 性别
- Female
入选标准
- •Age of 20 to 45 years
- •Symptomatic uterine fibroids candidate for laparoscopic surgery
- •No response to drug treatment
排除标准
- •Underlying diseases related to blood factors
- •Women who are candidates for hysterectomy
- •People for whom anesthesia is harmful
- •A history of an adverse reaction or allergy to vasopressin, and an active cardiovascular or pulmonary disease that indicates a problem with vasopressin use.
- •Long QT interval
- •Leiomyoma located in the area of the uterus that connects to the arteries or ligaments of the uterus or cervix and is difficult to remove without hysterectomy.
研究者
相似试验
尚未招募
不适用
A randomised controlled trial of intravenous versus intramuscular oxytocin in the management of third stage of labor.ACTRN12612000624886Khon Kaen Hospital450
已完成
3 期
Intravenous plus intramyometrial oxytocin versus intravenous cabetocin during caesarean section in prevention of post-partum hemorrhage: a randomized controlled trialpost partum hemorrhagepost partum hemorrhageintamyometriumoxytocincarbetocinTCTR20190829003Department of Medical Services50
Enrolling By Invitation
4 期
Comparison of different dosage of oxytocin for initiating uterine contraction during cesarean delivery: A randomized, double-blind, controlled, non-inferiority trialAdequate uterine contraction at 3 minutesUterine contraction (verbal numerical scale 0 ᆞ)Additional doses of uterotonic drugsAdditional obstetrics proceduresNausea/VomitingFlushingTachyoxytocininitiating uterine contractioncesarean deliveryTCTR20190415001Khon Kaen University160
已完成
4 期
Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean SectionsPostpartum HemorrhageNCT03651882University of Zurich550
尚未招募
3 期
To compare the effect of IM inj 10U oxytocin V/s Oral tablet Misoprostol in active management of third stage of labourCTRI/2024/07/070533I